ZBP is a biopharmaceutical company that has developed a proprietary technology to manufacture insulin and insulin analog-active pharmaceutical ingredients. Our technology simplifies and accelerates the production process, making our insulin and insulin analogs cost-competitive on a global scale. Source
No articles found.
The recognized global leader in neuromodulation devices to treat blindness, the co...
The recognized global leader in neuromodulation...
Syros is redefining the power of small molecules to control the expression of gene...
Syros is redefining the power of small molecule...
CytoDyn is a publicly traded late stage biotechnology company developing innovativ...
CytoDyn is a publicly traded late stage biotech...
CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in ...
CNS Pharmaceuticals is a pre-clinical stage bio...
Join the National Investor Network and get the latest information with your interests in mind.